L
Lila E. Nachtigall
Researcher at New York University
Publications - 73
Citations - 4812
Lila E. Nachtigall is an academic researcher from New York University. The author has contributed to research in topics: Estrogen & Menopause. The author has an hindex of 27, co-authored 72 publications receiving 4461 citations. Previous affiliations of Lila E. Nachtigall include Memorial Hospital of South Bend.
Papers
More filters
Journal ArticleDOI
The 2017 hormone therapy position statement of The North American Menopause Society.
JoAnn V. Pinkerton,Fernando Sánchez Aguirre,Jennifer Blake,Felicia Cosman,Howard N. Hodis,Susan Hoffstetter,Andrew M. Kaunitz,Sheryl A. Kingsberg,Pauline M. Maki,JoAnn E. Manson,Polly Marchbanks,Michael R. McClung,Lila E. Nachtigall,Lawrence M. Nelson,Diane Todd Pace,Robert L. Reid,Phillip M. Sarrel,Jan L. Shifren,Cynthia A. Stuenkel,Wulf H. Utian +19 more
TL;DR: Hormone therapy (HT) remains the most effective treatment for vasomotor symptoms and the genitourinary syndrome of menopause (GSM) and has been shown to prevent bone loss and fracture.
Journal ArticleDOI
Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems.
TL;DR: Results revealed no statistically significant difference in that incidence of thrombophlebitis, myocardial infarction (MI), or uterine cancer, and patients in the treated group who began the study with elevated beta/alpha lipoprotein ratios showed a reduction in that ratio over the course of the study.
Journal ArticleDOI
Testosterone Patch Increases Sexual Activity and Desire in Surgically Menopausal Women with Hypoactive Sexual Desire Disorder
James A. Simon,Glenn D. Braunstein,Lila E. Nachtigall,Wulf H. Utian,Molly Katz,Sam Miller,Arthur Waldbaum,Céline Bouchard,Christine Derzko,Akshay Buch,Cynthia Rodenberg,J. Lucas,Susan R. Davis +12 more
TL;DR: The Intimate SM 1 study as mentioned in this paper evaluated the efficacy and safety of a testosterone patch in surgically menopausal women with Hypoactive Sexual Desire Disorder (HSDD) after bilateral salpingo-oophorectomy.
Journal Article
Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder: results of the intimate SM1 study.
TL;DR: In the Intimate SM 1 study, the testosterone patch improved sexual function and decreased distress in surgically menopausal women with HSDD and was well tolerated in this trial.
Journal Article
Estrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis.
TL;DR: It is suggested that ERT could effectively reduce loss of bone mass associated with the postmenopausal state especially when administered within 3 years of LMP; it also confirmed David et.